Omk1® eye drops

Omk1® is a sterile ophthalmic solution containing Citicoline 2% and high molecular weight hyaluronic acid 0,2%.

The product has been developed by Omikron Italia and it is covered by International Patent for glaucoma treatment (EU, USA and Japan).

Omk1® is registered in Italy and also in other 39 EU and extra-EU Countries as Medical Device with CE Marking with the following intended use: “Thanks to the presence of Citicoline and to its structural action on retinal ganglion cells, it is indicated as coadjuvant to antihypertensive therapy in Glaucomatous patients.” 

Add-on treatment to hypotensive glaucoma therapy
to directly act on Retinal Ganglion Cells and on Optic Nerve head

This site is for healthcare professionals only

We remind you that the scientific contents published in citicolineomk1.com are intended only for professional users.

Therefore through the access you hereby state on your own responsibility to be a physicians or pharmacists.